MedPath

HOVID LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

135

PPB:135

Drug Approvals

TACROCORD 1 CAPSULES 1MG

Approval Date
Jun 17, 2025
PPB

TACROCORD 5 CAPSULES 5MG

Approval Date
Jun 17, 2025
PPB

TACROCORD 0.5 CAPSULES 0.5MG

Approval Date
Jun 17, 2025
PPB

HOVID ESOMEPRAZOLE GASTRO-RESISTANT TABLETS 40MG

Approval Date
Apr 24, 2025
PPB

HOVID ESOMEPRAZOLE GASTRO-RESISTANT TABLETS 20MG

Approval Date
Apr 24, 2025
PPB

HOVID CETIRIZINE TABLETS 10MG

Approval Date
Aug 16, 2024
PPB

HOVID POVIDONE-IODINE SOLUTION 10% W/V

Approval Date
Jun 28, 2024
PPB

MONTELAIR 4 CHEWABLE TABLETS 4MG

Approval Date
Mar 23, 2023
PPB

GASCOVID ADVANCE ORAL SUSPENSION

Approval Date
Nov 24, 2022
PPB

HOVID FULVESTRANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 250MG/5ML

Approval Date
Oct 5, 2022
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.